Detection of copeptin in peripheral blood of patients with aneurysmal subarachnoid hemorrhage

Table 12 Multivariate analysis of factors predicting one-year poor functional outcome among 303 patients

	Odds ratio	95% confidence interval	P value
WFNS score on admission	4.930	1.997~13.438	0.005
Modified Fisher score on admission	5.743	2.502~16.307	0.001
Aneurysmal size (mm)	1.129	0.782~1.337	0.137
Rebleeding	1.219	0.841~9.090	0.103
Acute hydrocephalus	1.132	0.730~8.004	0.218
Intracerebral hemorrhage	2.670	0.470~14.003	0.314
Intraventricular hemorrhage	2.404	0.817~12.337	0.087
External ventricular drain	1.316	0.718~4.796	0.316
Angiographic vasospasm	1.174	0.790~3.931	0.113
Computed tomography ischemia	1.422	0.849~3.640	0.139
Plasma C-reactive protein level (mg/L)	1.019	0.827~1.213	0.709
plasma D-dimer level (mg/L)	1.182	0.762~1.899	0.418
Plasma copeptin level (pmol/L)	1.253	1.109~1.504	0.001

The relation of copeptin to the poor functional outcome was assessed in a logistic-regression model. WFNS indicates World Federation of Neurological Surgeons.